| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer | Chief Business Officer
1 company
Kulkarni Samarth is a Chief Executive Officer at CRSP. Recent filings cover 0 purchases and 109 sales. Those positions are worth an estimated $15.5M at current prices.
Our model assigns Kulkarni Samarth a middling insider score of 68/100, based on 37 past trades. Over a 12-month horizon, 58.1% of those trades were profitable, with an average 12-month return of +7.5%.
Kulkarni Samarth's largest disclosed position is in CRSP as Chief Executive Officer, worth about $15.5M. The recent filings there lean toward selling, a net 1,049,894 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 28, 2022 | CRSP Crispr Therapeutics AG | Chief Executive Officer | Sale+OE | 25,000 | $54.03 | $1,350,826.80 | -7.9% | -7.8% | +32.5% | |
| Oct 26, 2022 | CRSP Crispr Therapeutics AG | Chief Executive Officer | Sale+OE | 25,000 | $54.81 | $1,370,191.05 | -7.9% | -5.9% | -29.1% | |
| Sep 28, 2022 | CRSP Crispr Therapeutics AG | Chief Executive Officer | Sale+OE | 25,000 | $64.61 | $1,615,160.24 | -7.9% | -38.7% | -31.7% | |
| Aug 29, 2022 | CRSP Crispr Therapeutics AG | Chief Executive Officer | Sale+OE | 25,000 | $66.84 | $1,671,084.48 | -7.9% | -18.9% | -23.1% | |
| Jul 27, 2022 | CRSP Crispr Therapeutics AG | Chief Executive Officer | Sale+OE | 25,000 | $75.91 | $1,897,747.33 | -7.9% | -33.5% | -29.8% | |
| Jun 29, 2022 | CRSP Crispr Therapeutics AG | Chief Executive Officer | Sale+OE | 25,000 | $61.59 | $1,539,861.52 | -7.9% | +1.0% | -9.5% | |
| Aug 5, 2021 | CRSP Crispr Therapeutics AG | Chief Executive Officer | Sale+OE | 30,000 | $128.78 | $3,863,468.55 | -13.8% | -27.4% | -39.0% | |
| Jun 15, 2021 | CRSP Crispr Therapeutics AG | Chief Executive Officer | Sale+OE | 30,000 | $126.43 | $3,792,804.19 | -13.8% | -4.5% | -49.3% | |
| Jan 15, 2021 | CRSP Crispr Therapeutics AG | Chief Executive Officer | Sale+OE | 20,000 | $213.67 | $4,273,311.04 | -9.9% | - | - | |
| Dec 10, 2020 | CRSP Crispr Therapeutics AG | Chief Executive Officer | Sale+OE | 20,000 | $142.29 | $2,845,781.82 | -10.6% | - | - |